Tenderwize
Retour à la recherche

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 131 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Baricitinib, ATC L04AF02

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Supply of pharmaceutical products containing Baricitinib
  • Non-exclusive discount agreements under §130a Abs. 8/130c Abs. 1 SGB V
Afficher le résumé complet

This is an open-house model for non-exclusive discount agreements (Rabattverträge) on the active ingredient Baricitinib (ATC L04AF02) by AOK Rheinland-Pfalz/Saarland. The procedure is not a formal EU procurement but a voluntary transparency publication. All interested pharmaceutical companies can join at any time during the 24-month maximum contract duration, with first possible start on 01.05.2025. No estimated value is provided. The contract may be replaced by exclusive agreements during its term.

Risques

The buyer reserves the right to replace open-house contracts with exclusive discount agreements at any time, automatica...

No commitment on minimum quantities or volumes; actual uptake depends on prescribing behavior and patient needs.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Pharmaceutical companies only
  • Products must be authorized and marketable in Germany
  • Proof of marketability via Lauer-Taxe listing or AMIce database

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria specified; all participants are accepted under uniform conditions.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open house discount agreements for the active ingredient Baricitinib, ATC L04AF02

Non-exclusive discount agreements for Baricitinib. All pharmaceutical companies can participate under uniform conditions. Contracts run for up to 24 months, starting 01.05.2025. The buyer may replace these with exclusive contracts at any time. First deadline for initial agreements: 31.03.2025; thereafter, monthly deadlines apply.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; all participants are accepted under uniform conditions.

Date limite

Expired Mar 31, 2025

Détails de la procédure

Date de publication
12 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
164264-2025

Documents (1)

Appels d'offres similaires